Meet the best- and worst-performing funds of 2016, per the Financial Times using data from Morningstar. Half of the top 20 losers were health or biotech equities funds, and the biggest losers were a sterling fund and another that made “big bets on a collapse in markets that did not pay off” top the list. An emerging markets fund that lost almost 28% was the third-worst performer. At the head of the class: Funds investing in gold and natural resources, and “five of the top performing funds were Russian equity products.”